EverHint – Dip Bounce V2 (Reclaim) – Top 5 Signals for Sep 29, 2026
Excerpt: 5 signals (from 29 total). Healthcare leads (12). price range $29-$296. 1 with insider buying. 1 with insider selling.
What This Signal Is
Production-ready dip-bounce strategy using reclaim pattern with Phase 2 market regime filters. Improved win rate from 40.42% (V1) to 50.18% (V2) with VIX and record high filters.
Entry Criteria:
- Minimum dip: 3.3% (open to intraday low)
- Minimum bounce: 1.0% from low
- Net change range: -2.0% to +0.3%
- Price above SMA(200)
- Minimum ADV: $40M
Holding period: 1-5 days | Risk level: Medium
Market Context
Equity markets are trading in a mild risk-off posture on September 29th, with all three major indices posting modest declines led by the Dow Jones at -0.26%. The moves are measured rather than alarming, suggesting a controlled pullback rather than a broad sentiment shift. For dip-bounce reclaim strategies, this type of shallow, broad-based softness can actually be constructive — it creates the minor dislocations and intraday dips that these setups are designed to exploit, without the chaotic price action that makes entries difficult to manage.
Volatility remains contained, with the VIX sitting at 16.04 and essentially flat on the day. This low-volatility environment compresses intraday ranges, which is a double-edged sword for dip-bounce signals: entries tend to be cleaner and stop levels more reliable, but profit targets may need to be calibrated tighter given the reduced swing potential. Traders should be mindful that in subdued VIX regimes, false reclaims can occur more frequently as price action lacks the momentum needed to sustain a meaningful bounce.
The concentration of signals in the Healthcare sector is notable and aligns with a broader pattern of defensive rotation often seen when large-cap growth indices like the Nasdaq show relative resilience compared to value-heavy indices like the Dow. Healthcare's defensive characteristics tend to attract capital during periods of mild uncertainty, providing a more stable backdrop for reclaim setups to play out. With 29 total signals generated, the opportunity set is reasonably broad, but sector concentration warrants attention to avoid overexposure to a single area of the market.
📊 Signals (5 of 29 total)
Ranked by dip magnitude (highest first)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | KOD | Kodiak Sciences Inc. | Healthcare | $91.12 | 0.53 | — | $5.7B |
| 2 | PFE | Pfizer Inc. | Healthcare | $28.73 | 0.42 | — | $163.7B |
| 3 | MRK | Merck & Co., Inc. | Healthcare | $149.32 | 0.32 | — | $368.8B |
| 4 | IT | Gartner, Inc. | Technology | $185.85 | 0.28 | — | $12.4B |
| 5 | CRL | Charles River Laborato... | Healthcare | $295.96 | 0.28 | — | $14.3B |
Field Notes
Sector concentration: Healthcare (12), Consumer Cyclical (4), Communication Services (3)
Data coverage: 3.4% insider (7d), 0.0% congressional (30d), 0.0% earnings, 13.8% news (7d)
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (12 signals) suggests sector-specific rotation. 1 signal with insider buying adds conviction.
Trading tips for this strategy:
- Entry timing: Consider entering on next-day weakness or at previous day's close level
- Position sizing: Start small (1-2% of portfolio per signal)
- Stop loss: Below today's low (tight stops for mean reversion)
- Take profit: 3-5% bounce target, or previous day's high
- Time stop: Exit if no bounce in 1-3 days
Risk warning: Mean reversion can fail in strong downtrends - check broader market context
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.